Bowel diseases and constipation in practice of the obstetrician and gynecologist
Abstract
The aim of review. To present up-to-date data on etiology, pathogenesis and treatment of constipation in women of various age groups and at combined gynecologic diseases.
Summary. Prevalence of functional constipation in women is almost twice higher, than in men. Predisposition of women to constipation is predetermined by anatomic, physiological and hormonal factors. In obstetrical practice constipation is associated with pregnancy and postnatal period, inflammatory and noninflammatory gynecologic diseases. This review presents modern management approaches at this pathology from gynecological point of view.
Conclusion. Disorders of intestinal function in women are interdisciplinary issue. At constipated female patients detection of intestinal dysfunction etiology and improvement of management, it is necessary to pay attention not only to gastroenterological symptoms, but also to possible relation of symptoms to menstrual cycle, reproductive status and gynecologic pathology. Constipation at gynecologic diseases require treatment because disorders of bowel function in the most cases complicate course of gynecologic disorder and reduces treatment response rate.
About the Authors
I. V. Kuznetsova
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Kuznetsova Irina V — professor, MD, PhD, chief research associate, Research department of women's health
119991, Moscow, Yelanskogo street, 2
Yu. B. Uspenskaya
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Uspenskaya Yu.B. — MD, leading research associate, Research department of women's health, Research-and-development center
119991, Moscow, Yelanskogo street, 2
References
1. Ерофеев Н. П., Радченко В. Г., Селиверстов П. В. Клиническая физиология толстой кишки. Механизмы действия короткоцепочечных жирных кислот в норме и при патологии. Санкт-Петербург: Форте Принт, 2012:c. 56.
2. Лоуренс Д. Р., Беннит П. Н. Клиническая фармакология: Пер. с англ. М.: Медицина, 1988; 2:238 с.
3. Попов А. А., Мананникова Т. Н., Шагинян Г. Г., Мачанските О. В., Рамазанов М. Р., Чечнева М. А., Кирюшкина О. Г. Современный подход к коррекции ректоцеле у гинекологических больных с пролапсом гениталий. Рос вестн акушера-гинеколога 2006; 6(2):67-71.
4. Bani D., Baccari M. C., Quattrone S., Nistri S., Calamai F., Bigazzi M., Bani Sacchi T. Relaxin depresses small bowel motility through a nitric oxidemediated mechanism. Studies in mice. Biol Reprod 2002; 66(3):778-84.
5. Bouchoucha M., Thomas S. R. Error analysis of classic colonic transit time estimates. Am J Physiol Gastrointest Liver Physiol 2000; 279(3):520-7.
6. Bradley C. S., et al. Constipation in pregnancy: prevalence, symptoms, and risk factors. Obstet Gynecol 2007; 66(11):1351-1357.
7. Choijookhuu N., Sato Y., Nishino T., Endo D., Hishikawa Y., Koji T. Estrogen-dependent regulation of sodium/hydrogen exchanger-3 (NHE3) expression via estrogen receptor in proximal colon of pregnant mice. Histochem Cell Biol 2012; 137(5):575-87.
8. Christofides N., Ghatei M., Bloom S., Borberg C., Gillmer M. Decreased plasma motilin concentrations in pregnancy. Br Med J (Clin Res Ed) 1982; 285(6353):1453-4.
9. Coco A. S. Primary dysmenorrhea. Am Fam Physician 1999; 60 (2):489-96.
10. Friedrich C., Richter E., Trommeshauser D., de Kruif S., van Iersel T., Mandel K., Gessner U. Absence of excretion of the active moiety of bisacodyl and sodium picosulfate into human breast milk: an open-label, parallel-group, multiple-dose study in healthy lactating women. Drug Metab Pharmacokinet 2011; 26(5):458-64.
11. Halligan S., Bertram C. I. Is barium trapping in rectoceles significant? Dis Colon Rectum 1995; 38:764-8.
12. Harari D., Gurwitz J. H., Avorn J., Bohn R., Minaker K. L. Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med 1996; 156:315-20.
13. Heitkemper M. M., Cain K. C., Jarrett M. E., Burr R. L., Hertig V., Bond E. F. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Am J Gastroenterol 2003; 98:420-30.
14. Hoechstetter L., et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981; 80(6):1497-500.
15. Houghton L. A., Lea R., Jackson N., Whorwell P. J. The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. Gut 2002; 50(4):471-4.
16. Jewell D. J., Young G. Interventions for treating constipation in pregnancy. Cochrane Database Syst Rev 2001; (2): CD001142.
17. Karasick S., Karasick D., Karasick S. R. Functional disorders of the anus and rectum: findings on defecography. AJR 1993; 160:777-82.
18. Kern F. Jr., Everson G. T., DeMark B., et al. Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle. J Clin Invest 1981; 68:1229-42.
19. Kiaii B., Xu Q. W., Shaffer E. A. The basis for progesterone impairment of gallbladder contractility in male guinea pigs in vitro. J Surg Res 1998; 79 (2):97-102.
20. Mahadevan U., Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006; 131(1):283-311.
21. Manabe N., Tanaka T., Hata J., Kusunoki H., Harumaт K. Pathophysiology underlying irritable bowel syndrome — from the viewpoint of dysfunction of autonomic nervous system activity. J Smooth Muscle Res 2009; 45 (1):15-23.
22. Mathias J. R., Clench M. H., et al. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study. Dig Dis Sci 1994; 39:1155-62.
23. Meier P. R., Nickerson H. J., Olson K. A., et al. Prevention of iron deficiency anemia in adolescent and adult pregnancies. Clin Med Res 2003; 1:29-36.
24. Norton P. A. Pelvic floor disorders: the role of fascia and ligaments. Clin Obstet Gynecol 1993; 36(4):926-38.
25. Pare P., Ferrazzi S., Thompson W. G., Irvine E. J., Rance L. An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterol 2001; 96:3130-7.
26. Pohl D., Tutuian R., Fried M. Pharmacologic treatment of constipation: what is new? Curr Opin Pharmacol 2008; 8(6):724-8.
27. Ponce J., et al. Constipation during pregnancy: a longitudinal survey based on self-reported symptoms and the Rome II criteria. Eur J Gastroenterol Hepatol 2008; 20:56-61.
28. Rees W. D., Rhodes J. Wald A., van Thiel D. H. Altered bowel habit and menstruation. Lancet 1976; 1(7982):475.
29. Rosato G. O. Rectocele and perineal hernias. In: D. E. Beck, S. D. Wexner, eds. Fundamentals of Anorectal Surgery. London: WB Saunders; 1998:99-114.
30. Rowland R. S., Bell G. D., Dogramadzi S., Allen C. Colonoscopy aided by magnetic 3D imaging: Is the technique sufficiently sensitive to detect differences between men and women? Med Biol Eng Comput 1999; 37:673-9.
31. Shah S., Hobbs A., Singh R., Cuevas J., Ignarro L. J., Chaudhuri G. Gastrointestinal motility during pregnancy: role of nitrergic component of NANC nerves. Am J Physiol Regul Integr Comp Physiol 2000; 279(4):1478-85.
32. Soffer E. E., Kongara K., Achkar J. P., Gannon J. Colonic motor function in humans is not affected by gender. Dig Dis Sci 2000; 45(7):1281-4.
33. Stewart W. F., Liberman J. N., Sandler R. S., et al. Epidemiology of Constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999; 94:3530-40.
34. Streett S. E. Endoscopic colorectal cancer screening in women: Can we do better? Gastrointest Endosc 2007; 65:1047-9.
35. Takeuchi K., Kato S., Tanaka A. Gastrointestinal protective action of prostaglandin E2 and EP receptor subtypes. In: Cho C.-H., Wang J.-Y., eds. Gastrointestinal Mucosal Repair and Experimental Therapeutics. Basel, Switzerland: Karger, 2002:227-42.
36. Xiao Z. L., Pricolo V., Biancani P., Behar J. Role of progesterone signaling in the regulation of G-protein levels in female chronic constipation. Gastroenterology 2005; 128(3):667-75.
37. Wald A., Van Thiel D. H., Hoechstetter L., et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981; 80(6):1497-500.
38. Zygmunt M., Heilmann L., Berg C., et al. Local and systemic tolerability of magnesiumsulphate for tocolysis. Eur J Obstet Gynecol Reprod Biol 2003; 107:168-75.
Review
For citations:
Kuznetsova I.V., Uspenskaya Yu.B. Bowel diseases and constipation in practice of the obstetrician and gynecologist. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2015;25(1):30-36. (In Russ.)
Views:
481
Email this article 
